Market Outlook

By 2035, the U.S. Orthopedic Procedure Devices Market is expected to reach approximately USD 69.99 billion, growing at a CAGR of 7.25% during the forecast period 2026–2035. The market was valued at USD 34.76 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

The U.S. orthopedic procedure devices industry represents a clinically essential and economically significant part of the country’s medical device sector. For the purpose of this report, the market includes implantable devices, procedure-specific instruments, powered surgical systems, arthroscopy equipment, navigation and robotic platforms, fixation systems, surgical disposables, and orthobiologic adjuncts used during orthopedic interventions. Diagnostic imaging systems, external braces, prosthetic limbs, rehabilitation equipment, and general-purpose operating room products are excluded unless they are specifically configured for an orthopedic procedure.

Demand is supported by a large and expanding population with osteoarthritis, degenerative joint disease, osteoporosis, spinal disorders, traumatic fractures, sports injuries, tendon and ligament damage, and age-related mobility impairment. More than 61 million people aged 65 and older were living in the United States in 2024, while arthritis affects tens of millions of adults. Diagnosed arthritis prevalence rises sharply with age and exceeds half of the population among adults aged 75 and older. These demographic and disease patterns create recurring demand for knee, hip, shoulder, spine, trauma, foot and ankle, hand and wrist, and sports medicine procedures.

The market is moving beyond conventional implants and manual instrumentation toward a connected orthopedic procedure ecosystem. Robotic-assisted arthroplasty, handheld robotic tools, computer navigation, patient-specific planning, 3D-printed implants, cementless fixation, smart surgical instruments, minimally invasive spine systems, biologic augmentation, and data-driven postoperative monitoring are becoming more influential in hospital purchasing decisions. Health systems increasingly evaluate orthopedic technologies according to their effect on implant positioning, procedure reproducibility, operating room utilization, staffing requirements, length of stay, revision risk, and the feasibility of moving appropriate procedures into ambulatory settings.

The historical market expanded from approximately USD 25.46 billion in 2021 to USD 32.38 billion in 2024. Growth during this period was supported by the recovery of elective orthopedic procedures, normalization of hospital surgical capacity, increasing outpatient joint replacement, stronger demand for trauma and extremity fixation, and renewed capital spending on robotics and navigation. The market reached USD 34.76 billion in 2025 as health systems increased investment in procedure standardization, ambulatory surgery infrastructure, robotic platforms, surgical planning, and premium implant technologies.

 

Introduction

According to the U.S. Orthopedic Procedure Devices Market Report, the industry is shaped by a combination of aging demographics, high musculoskeletal disease prevalence, advanced orthopedic specialist networks, established reimbursement pathways, and strong patient demand for restored mobility. Orthopedic care is highly procedure-intensive because definitive treatment frequently depends on implantation, bone preparation, fixation, tissue repair, decompression, alignment correction, or reconstruction. This creates demand for both high-value implants and recurring procedure-specific consumables.

The market is not limited to hip and knee replacement. It extends across trauma fixation, spine surgery, arthroscopy, ligament reconstruction, rotator cuff repair, shoulder arthroplasty, foot and ankle reconstruction, hand and wrist procedures, fracture repair, revision surgery, and biologically assisted bone healing. Mature categories such as total knee implants, hip stems, bone plates, screws, intramedullary nails, spinal cages, and manual instruments provide a stable base of recurring demand. Higher-growth categories such as robotic-assisted surgery, cementless implants, enabling technologies, biologically integrated fixation, patient-specific instrumentation, and minimally invasive procedural systems are adding incremental value.

The addressable U.S. infrastructure is substantial. The country has more than 900,000 staffed hospital beds, more than 32 million annual community hospital admissions, a large network of ambulatory surgery centers, and thousands of orthopedic practices. Academic medical centers and high-volume specialty hospitals frequently act as early adopters of advanced procedure technologies, while integrated delivery networks influence broader market access through enterprise purchasing agreements and implant standardization programs.

Procedure demand is further demonstrated by the scale of national orthopedic registries. The American Joint Replacement Registry has accumulated data covering millions of hip and knee arthroplasty procedures from institutions across all 50 states. Its expanding coverage reflects both the volume of joint replacement activity and the growing importance of implant surveillance, patient-reported outcomes, and evidence-based procurement.

The economic model of orthopedic care is also changing. Hospitals historically evaluated orthopedic devices primarily according to implant price, surgeon preference, and distributor support. Procurement decisions now incorporate the complete cost of the surgical episode. Decision-makers examine operating room time, instrument tray requirements, sterilization expense, postoperative complications, discharge destination, readmissions, implant survivorship, revision exposure, and patient-reported outcomes. A premium device may be accepted when it can demonstrate measurable economic or clinical value across the full care pathway.

From 2026 to 2035, the defining strategic shift will be the transition from isolated implants toward integrated orthopedic procedure platforms. Manufacturers that combine implants, instruments, robotic or navigational guidance, procedural analytics, clinical education, supply-chain support, and outcomes documentation will be positioned more strongly than manufacturers competing through stand-alone products. The most successful platforms will help providers perform predictable procedures in both hospital and ambulatory environments without adding excessive capital, staffing, or workflow complexity.

 

Key Market Drivers: What’s Fueling the U.S. Orthopedic Procedure Devices Market Boom?

The first major driver is the size of the U.S. musculoskeletal disease burden. Arthritis is one of the country’s most common chronic conditions and a major cause of pain, functional limitation, and disability. Osteoarthritis is especially important for the orthopedic procedure devices market because progressive cartilage loss in the knee, hip, shoulder, and smaller joints can lead to arthroplasty or other reconstructive procedures when conservative care no longer provides adequate relief. A separate burden is created by spinal stenosis, degenerative disc disease, vertebral instability, and deformity, which support demand for decompression, fusion, fixation, and motion-preservation systems.

The second driver is rapid population aging. The U.S. population aged 65 and older has expanded significantly since 2020 and is increasing faster than many younger age groups. Older adults undergo a disproportionate share of inpatient procedures and diagnostic services. They also experience higher rates of osteoarthritis, osteoporosis, fragility fractures, spinal degeneration, and loss of joint function. This demographic shift creates a durable demand pool for arthroplasty, fracture fixation, spine surgery, and revision procedures.

The third driver is the scale of orthopedic trauma and fall-related injury. Older adult falls generate millions of emergency department visits, while hip fractures account for approximately 300,000 hospitalizations annually. Road accidents, workplace injuries, recreational activity, and sports participation add further demand for plates, screws, nails, external fixation, intramedullary systems, bone graft materials, and soft-tissue repair devices. Trauma demand is less discretionary than elective arthroplasty and therefore gives the market resilience during periods of economic uncertainty.

The fourth driver is expansion of outpatient orthopedic surgery. Total knee arthroplasty, total hip arthroplasty, partial knee replacement, arthroscopy, foot and ankle surgery, hand surgery, and selected spine procedures are increasingly performed in hospital outpatient departments and ambulatory surgery centers when patient selection is appropriate. Medicare payment policies and quality measures have helped formalize outpatient joint replacement pathways. Commercial payers are also encouraging movement to lower-cost sites of care.

This transition changes the type of technology providers require. Ambulatory facilities generally prefer compact equipment, fewer instrument trays, efficient room turnover, predictable disposable costs, simplified sterilization, and technologies that do not require large technical teams. Orthopedic companies that can redesign hospital-grade procedure platforms around ASC workflow and economics will gain access to a rapidly expanding customer base.

The fifth driver is continuing growth in robotic-assisted and navigated orthopedic surgery. Robotic systems can support surgical planning, implant alignment, bone preparation, soft-tissue balancing, and procedural reproducibility. Their strategic value extends beyond technical accuracy. Hospitals use orthopedic robotics to attract surgeons, differentiate service lines, market advanced care, standardize procedural execution, and support higher operating room utilization. Robotics can also strengthen implant pull-through because many platforms are linked to proprietary implant portfolios.

The sixth driver is demand for improved implant durability and lower revision risk. Revision arthroplasty, failed fracture fixation, spinal reoperation, infection, nonunion, loosening, instability, and implant wear create significant clinical and economic burdens. Providers increasingly favor materials, fixation technologies, coatings, instrumentation, and planning systems that can improve initial stability and long-term performance. Cementless knee implants, porous metal structures, advanced bearing surfaces, patient-specific alignment strategies, and biologically supportive fixation are benefiting from this emphasis.

The seventh driver is obesity and its effect on musculoskeletal disease. Adult obesity remains prevalent across the United States, with numerous states reporting obesity rates above 35%. Excess body weight increases mechanical loading on the knee, hip, ankle, and spine and can accelerate osteoarthritis progression. Obesity also increases the technical complexity of orthopedic surgery and may raise infection, wound, thromboembolic, and revision risk. This creates demand for durable implants, improved instrumentation, procedural planning, wound-management protocols, and technologies capable of supporting complex patient anatomy.

The eighth driver is hospital consolidation and enterprise procurement. Large health systems increasingly control orthopedic purchasing across multiple hospitals, ASCs, and physician practices. These organizations use value analysis committees, competitive tenders, implant price benchmarking, and preferred-vendor agreements to reduce variation. Manufacturers must therefore demonstrate value at both the surgeon and corporate levels. A product may require clinical advocacy from orthopedic specialists, economic approval from administrators, operational acceptance from perioperative teams, and contracting approval from supply-chain leadership.

The ninth driver is the expansion of patient-reported outcome measurement. Medicare and commercial payers are paying greater attention to functional improvement after hip and knee replacement. Patient-reported outcome measures make it more important for providers to track pain, mobility, activity, and quality of life before and after surgery. Device companies that can connect procedural information with longitudinal outcomes will be better positioned to support value-based contracts and defend premium pricing.

The tenth driver is the depth of the U.S. innovation ecosystem. The country contains a high concentration of orthopedic surgeons, research institutions, medical device manufacturers, private equity investors, clinical trial centers, and specialized distributors. This ecosystem accelerates development in robotics, surgical planning, orthobiologics, implant materials, 3D printing, smart instrumentation, and minimally invasive techniques. New products can achieve rapid adoption when clinical evidence, surgeon training, reimbursement alignment, and procedural economics are addressed simultaneously.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. orthopedic procedure devices market is increasingly focused on procedural consistency rather than the implant alone. Manufacturers are developing systems that guide patient selection, surgical planning, implant placement, tissue balancing, intraoperative verification, and postoperative outcomes measurement. This approach reflects the reality that implant performance depends on the quality of the entire procedure.

Robotic-assisted arthroplasty is the most visible innovation area. Traditional robotic systems have generally required large capital investments, dedicated footprints, preoperative imaging, or specialized technical support. The next innovation cycle is expanding into smaller, more flexible platforms. Handheld robotic systems, imageless navigation, modular platforms, and multi-procedure robots are intended to reduce adoption barriers and extend advanced guidance into community hospitals and ASCs.

Competitive differentiation is shifting from whether a company offers robotics to how effectively the robotic platform fits clinical workflow. Systems are being compared according to registration time, preoperative imaging requirements, cutting efficiency, surgeon control, procedure compatibility, instrument burden, service requirements, and cost per case. The strongest platforms will be those that increase reproducibility without causing delays or requiring an uneconomic level of infrastructure.

Patient-specific planning is another important growth area. Preoperative CT, MRI, or radiographic data can be used to model anatomy, evaluate deformity, select implant size, plan alignment, and prepare patient-specific instruments. In shoulder and complex extremity procedures, 3D planning is particularly valuable because anatomy can vary substantially between patients. Planning software is also becoming more closely linked with robotic execution, navigation, implant selection, and postoperative analytics.

Cementless fixation is reshaping knee arthroplasty. Historically, bone cement was the dominant fixation method in total knee replacement. Improvements in porous coatings, additive manufacturing, implant geometry, and bone ingrowth surfaces have increased interest in cementless systems, particularly among younger and more active patients. Cementless fixation can reduce cement-related workflow and may provide durable biologic fixation, although adoption depends on bone quality, surgeon training, patient selection, and long-term evidence.

Three-dimensional printing is supporting both standard and customized orthopedic devices. Additive manufacturing enables porous structures that encourage bone integration, complex geometries that are difficult to machine conventionally, and patient-specific implants for severe bone loss or unusual anatomy. Applications include acetabular components, spinal cages, trauma implants, revision devices, and custom reconstruction systems. Wider adoption will depend on manufacturing quality, regulatory controls, turnaround time, and economic justification.

Smart and sensor-enabled orthopedic technologies are emerging as a new competitive layer. Sensors can be used to measure load, balance, position, movement, or rehabilitation progress. Intraoperative sensors may help surgeons evaluate soft-tissue balance or implant positioning, while postoperative monitoring can support recovery management. These technologies are not expected to replace clinical judgment, but they can add objective data to procedure execution and follow-up.

Minimally invasive spine surgery continues to evolve through smaller access corridors, percutaneous fixation, expandable cages, navigated instrumentation, robotic screw placement, and advanced visualization. The economic objective is to reduce tissue disruption, blood loss, pain, length of stay, and recovery time. Hospitals and ASCs are particularly interested in systems that allow selected spine procedures to be completed through predictable workflows with reduced instrument and imaging burden.

Sports medicine innovation is focused on biologically integrated soft-tissue repair. Knotless anchors, all-suture anchors, advanced suture materials, meniscal repair devices, graft preparation systems, and biologic scaffolds are intended to improve fixation while minimizing bone removal and procedure complexity. Arthroscopic visualization, fluid management, powered shavers, radiofrequency systems, and disposable instruments are also being redesigned to improve efficiency and image quality.

Trauma innovation is addressing complex anatomy, fragility fractures, and operating room efficiency. Anatomically contoured plates, variable-angle locking screws, intramedullary nails, minimally invasive insertion systems, and fracture-specific instruments allow surgeons to treat a wider range of injuries. Manufacturers are also reducing tray counts and developing procedure-specific sterile kits, which can be attractive to trauma centers facing unpredictable case timing and sterilization pressure.

Orthobiologic innovation is focused on improving fusion, bone healing, tendon repair, and management of nonunion. Bone graft substitutes, demineralized bone matrix, cellular allografts, synthetic graft materials, growth-factor technologies, and bone stimulation devices are increasingly evaluated according to evidence quality and cost. The category offers meaningful growth potential, but it also faces reimbursement variability and greater scrutiny regarding clinical claims.

Manufacturers are raising the competitive bar through evidence generation. Registry data, randomized studies, implant survivorship analysis, patient-reported outcomes, real-world evidence, and health economic models are becoming more important. Hospitals increasingly expect companies to demonstrate that a new device improves more than radiographic alignment. Evidence must address complications, operating time, recovery, revision risk, patient function, and total episode cost.

 

Segmentation Insights

The U.S. Orthopedic Procedure Devices Market is segmented on the basis of device category, procedure type, anatomical site, technology, and end user.

 

By Device Category

Joint Reconstruction Devices

Joint reconstruction devices represent the largest device category by value. The segment includes knee implants, hip implants, shoulder systems, partial joint implants, revision components, trial implants, cutting guides, broaches, reamers, alignment instruments, and procedure-specific disposables. Knee and hip replacement account for most segment revenue, while shoulder and extremity reconstruction provide faster percentage growth.

Demand is supported by osteoarthritis prevalence, expanding outpatient arthroplasty, improved implant survivorship, and greater willingness among active adults to undergo surgery before severe functional decline. Premium growth is concentrating in cementless fixation, personalized alignment, robotic-compatible implants, revision systems, and technologies designed to reduce instrument burden.

Trauma Fixation Devices

Trauma fixation devices include bone plates, screws, intramedullary nails, wires, pins, external fixation systems, fracture reduction instruments, and pelvic or acetabular reconstruction devices. Demand is generated by acute fractures, sports injuries, road accidents, occupational injuries, and fragility fractures among older adults.

The segment has a durable recurring-consumable profile because implants are used per procedure. Growth opportunities are strongest in anatomical plating, minimally invasive fixation, geriatric fracture systems, small-bone fixation, sterile-packed implants, and integrated trauma instrument sets. Clinical support and inventory availability are critical because many trauma procedures are urgent and cannot be delayed by supply constraints.

Spine Procedure Devices

Spine procedure devices include pedicle screw systems, rods, interbody cages, cervical plates, artificial discs, expandable implants, vertebral augmentation systems, navigation-compatible instruments, and biologic fusion materials. The segment serves degenerative disc disease, spinal stenosis, instability, deformity, trauma, and vertebral compression fractures.

Growth is being driven by minimally invasive surgery, outpatient migration, expandable interbody systems, robotic screw placement, navigation, and 3D-printed cages. Nevertheless, spine procurement remains sensitive to evidence, surgeon preference, payer authorization, and scrutiny of procedure appropriateness.

Sports Medicine and Arthroscopy Devices

Sports medicine and arthroscopy devices include suture anchors, interference screws, meniscal repair systems, ligament reconstruction devices, graft preparation tools, arthroscopes, shavers, pumps, fluid-management systems, radiofrequency probes, and visualization accessories. Knee and shoulder procedures account for a large share of demand, followed by hip, elbow, wrist, and ankle arthroscopy.

The segment benefits from sports participation, active aging, younger patient demographics, and the movement of procedures to ASCs. Recurring disposables create an attractive revenue model. Manufacturers differentiate through anchor design, suture strength, ease of deployment, bone preservation, procedural efficiency, and integration with visualization platforms.

Extremity Procedure Devices

Extremity procedure devices cover shoulder, elbow, wrist, hand, foot, and ankle reconstruction and fixation. Products include small-joint implants, ankle replacement systems, bunion correction devices, fusion plates, screws, intramedullary fixation, and patient-specific instruments.

This category is growing faster than many mature large-joint segments because of innovation, specialist practice expansion, and historical underpenetration. Foot and ankle procedures are particularly attractive due to procedure diversity and the expanding role of ambulatory specialty centers. Shoulder arthroplasty is also benefiting from reverse shoulder systems, preoperative planning, and robotic assistance.

Orthopedic Instruments, Power Tools, and Enabling Systems

This category includes drills, saws, reamers, shavers, handpieces, batteries, consoles, manual instrument sets, navigation platforms, robotic systems, and related accessories. Revenue includes capital equipment, reusable instruments, disposable accessories, software, service, and procedure-linked consumables.

Hospitals evaluate these technologies according to reliability, sterilization compatibility, battery performance, ergonomics, service coverage, procedural speed, and cross-specialty utility. Growth is strongest in robotic platforms, handheld navigation, battery-powered instruments, compact ASC systems, and technologies that reduce the number of trays required per procedure.

 

By Procedure Type

Joint Arthroplasty

Joint arthroplasty is the largest procedure segment and includes total knee, partial knee, total hip, shoulder, ankle, elbow, and small-joint replacement. Knee and hip arthroplasty dominate procedure value because of high volumes and established reimbursement.

The segment is being reshaped by outpatient migration, robotic-assisted surgery, cementless fixation, same-day discharge, and personalized alignment. Hospitals and ASCs are investing in standardized pathways that combine implants, anesthesia protocols, infection prevention, rehabilitation planning, and patient selection.

Fracture Fixation and Trauma Reconstruction

This segment includes internal fixation, external fixation, intramedullary nailing, fracture reduction, and reconstructive trauma procedures. Demand is influenced by fall-related injuries, road accidents, sports injuries, workplace trauma, and osteoporosis.

Hip fractures among older adults create substantial hospital demand, while wrist, ankle, clavicle, and small-bone fractures support both hospital and ambulatory procedures. Growth is strongest in minimally invasive fixation, anatomical plating, fragility-fracture systems, and implants designed for poor bone quality.

Spinal Fusion, Decompression, and Stabilization

Spinal procedures include cervical and lumbar fusion, decompression, discectomy, deformity correction, vertebral augmentation, and motion-preservation surgery. The category combines high-value implants with navigation, imaging, instruments, and biologic materials.

Complex spine procedures will remain concentrated in hospitals, while selected decompression and fusion procedures will increasingly move to outpatient facilities. Adoption will depend on payer authorization, patient risk, surgeon experience, and the ability to achieve predictable recovery.

Arthroscopy and Soft-Tissue Repair

Arthroscopy and soft-tissue repair include anterior cruciate ligament reconstruction, meniscal repair, rotator cuff repair, labral repair, cartilage procedures, and tendon reconstruction. Most cases are minimally invasive and increasingly performed in ASCs.

The segment benefits from recurring device use and high surgeon sensitivity to workflow. Products that simplify anchor placement, graft preparation, suture management, and tissue fixation can gain rapid adoption when supported by training and clinical evidence.

Extremity Reconstruction and Corrective Procedures

This segment includes bunion correction, foot and ankle fusion, shoulder reconstruction, hand and wrist fixation, tendon balancing, deformity correction, and small-joint replacement. It is characterized by a high number of specialized procedures and product configurations.

Specialist-focused companies can compete effectively because large manufacturers may not address every anatomical niche. Market success depends on surgeon education, local inventory, procedure-specific instruments, and responsive clinical support.

Revision and Salvage Procedures

Revision procedures involve removal or replacement of failed implants, management of infection, correction of instability, treatment of bone loss, and reconstruction after failed fixation or arthroplasty. These procedures are lower in volume than primary surgery but substantially higher in complexity and device value.

Demand for revision systems will increase as the installed base of orthopedic implants expands. Modular implants, cones, augments, custom components, extraction tools, and biologic materials are especially important in this segment.

 

By Anatomical Site

Knee

The knee is the largest anatomical segment. It includes total and partial knee arthroplasty, ligament reconstruction, meniscal repair, cartilage procedures, osteotomy, patellar repair, and fracture fixation. High osteoarthritis prevalence and large replacement volumes create recurring demand.

Knee procedures are the most developed application for orthopedic robotics. Future growth will be supported by cementless implants, robotic-compatible systems, patient-specific planning, outpatient pathways, and revision demand.

Hip and Pelvis

The hip and pelvis segment includes total hip arthroplasty, hemiarthroplasty, hip fracture fixation, pelvic reconstruction, acetabular fixation, hip arthroscopy, and revision surgery. Demand is strongly linked to aging and fall-related fractures.

The segment is also benefiting from direct anterior surgical approaches, navigation, robotic guidance, dual-mobility implants, porous revision components, and technologies intended to reduce dislocation risk.

Spine

The spine segment covers cervical, thoracic, and lumbar procedures. It includes fusion, decompression, stabilization, disc replacement, vertebral augmentation, and deformity correction.

Growth is shifting toward minimally invasive approaches, expandable implants, robotic navigation, patient-specific planning, and procedures suitable for shorter hospital stays. Complex deformity and revision cases will remain high-value hospital procedures.

Shoulder

Shoulder procedures include rotator cuff repair, labral repair, fracture fixation, anatomic shoulder arthroplasty, and reverse shoulder arthroplasty. Reverse shoulder systems have expanded the treatable population and contributed to strong market growth.

Preoperative 3D planning and robotic-assisted shoulder arthroplasty are emerging as important competitive areas. The shoulder segment is expected to record above-average growth through 2035.

Foot and Ankle

Foot and ankle procedures include bunion correction, ankle fusion, total ankle replacement, fracture fixation, tendon repair, and deformity reconstruction. Many procedures are suitable for specialty hospitals and ASCs.

The market supports both large orthopedic companies and focused innovators. Growth is being driven by procedure-specific implants, minimally invasive correction systems, improved ankle replacement designs, and increasing specialist adoption.

Hand, Wrist, and Elbow

This segment includes fracture fixation, carpal procedures, tendon repair, small-joint replacement, ligament reconstruction, and elbow arthroplasty. Procedure volumes are high, although average revenue per case is generally lower than large-joint reconstruction.

Opportunity is concentrated in low-profile fixation, small-bone implants, sterile kits, all-suture devices, and instruments designed for ambulatory workflows.

 

By Technology

Conventional Manual Systems

Conventional instruments and manually executed procedures continue to account for the largest installed procedural base. Many experienced surgeons achieve predictable outcomes without robotics, particularly in trauma, arthroscopy, extremity surgery, and standard arthroplasty.

Manual systems will remain important because of lower capital cost, surgeon familiarity, broad implant compatibility, and suitability for facilities with limited case volume. Manufacturers continue to improve these systems through lighter instruments, reduced tray counts, and disposable cutting guides.

Powered Surgical Instruments

Powered drills, saws, reamers, shavers, and wire drivers are essential across orthopedic procedures. Innovation is focused on battery performance, torque, ergonomics, heat control, sterilization resistance, and integration with navigation.

The replacement cycle for power equipment creates stable capital demand, while blades, burs, batteries, and accessories generate recurring revenue.

Minimally Invasive and Arthroscopic Systems

Minimally invasive technologies include arthroscopy systems, percutaneous fixation, small-incision spine platforms, cannulated instruments, and endoscopic visualization. These technologies align with provider objectives to reduce tissue trauma, recovery time, and length of stay.

Demand is strongest in ASCs and outpatient hospital departments. Products must balance reduced invasiveness with visualization, procedural control, and operating room efficiency.

Navigation and Robotic-Assisted Systems

Navigation and robotics represent the fastest-growing technology segment. Applications are expanding from knee and hip arthroplasty into shoulder, spine, and other orthopedic procedures.

Competitive success depends on system footprint, capital model, implant compatibility, workflow, data integration, and the strength of supporting clinical evidence. Leasing, placement agreements, and procedure-linked pricing are becoming increasingly important commercial models.

Patient-Specific, 3D-Printed, and Smart Technologies

This segment includes custom implants, patient-specific guides, porous additive-manufactured implants, mixed-reality navigation, AI-supported planning, and sensor-enabled instruments or implants.

Although the segment currently accounts for a smaller market share, it is expected to expand rapidly as hospitals seek greater personalization and manufacturers improve production scalability. Adoption will be strongest in complex reconstruction, revision surgery, severe deformity, and procedures where conventional components provide an imperfect anatomical fit.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated delivery networks are the dominant end users. They account for most complex arthroplasty, trauma, spine, revision, and high-risk orthopedic procedures. Large systems negotiate enterprise contracts, standardize implant portfolios, and use value analysis committees to evaluate new technologies.

Manufacturers serving these customers must provide reliable inventory, operating room support, surgeon training, reimbursement assistance, service coverage, and supply-chain resilience. Contracting flexibility can be as important as product performance.

Ambulatory Surgery Centers

ASCs are the fastest-growing end-user segment. Growth is supported by outpatient joint replacement, arthroscopy, foot and ankle surgery, hand procedures, and selected spine interventions.

ASCs prioritize predictable cost per case, compact equipment, rapid turnover, limited tray requirements, and same-day discharge. Device manufacturers are creating ASC-specific implant bundles, portable robotics, disposable instruments, and simplified logistics models.

Orthopedic Specialty Hospitals and Clinics

Specialty orthopedic hospitals combine high procedure volumes with focused clinical infrastructure. They are important adopters of robotic arthroplasty, advanced sports medicine, spine surgery, and standardized recovery pathways.

Orthopedic clinics also influence device selection through surgeon ownership, referral patterns, and participation in ambulatory facilities. Office-based procedure opportunities remain more limited but are expanding in injection, biologic, minor fixation, and postoperative management.

Academic Medical Centers and Level I Trauma Centers

Academic centers and major trauma hospitals are strategically important for complex cases, clinical trials, surgeon training, and evidence generation. They often evaluate novel implants, robotics, navigation, biologics, and custom reconstruction technologies before wider market adoption.

These institutions require extensive clinical evidence and technical support. Their purchasing decisions can influence referral networks and national surgeon opinion.

Community and Rural Providers

Community hospitals and rural providers represent a large but operationally challenging customer group. Many depend on visiting specialists, regional referral pathways, and distributor-supported inventory.

Products that offer reliability, simplified training, reduced tray burden, remote technical support, and broad procedural utility are particularly attractive in these settings.

 

Regional Insights: Where the Market Is Growing Fastest

The U.S. Orthopedic Procedure Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance varies according to population size, age distribution, arthritis and obesity prevalence, hospital and ASC density, specialist concentration, trauma burden, reimbursement mix, and adoption of robotic or minimally invasive procedures.

The South represented the largest regional market in 2025, while the West is expected to record the fastest growth through 2035. The Northeast remains a high-value market for complex procedures and premium innovation, while the Midwest provides a stable base of mature orthopedic procedure demand.

South

The South accounted for an estimated USD 12.86 billion in 2025. The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Delaware, Tennessee, Kentucky, West Virginia, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and the District of Columbia. Its leadership is supported by population scale, strong migration, high obesity and arthritis burden, expanding older populations, and continued investment in hospital and ASC infrastructure.

Texas is one of the country’s largest orthopedic procedure markets. Houston, Dallas–Fort Worth, Austin, and San Antonio contain major health systems, trauma centers, orthopedic groups, and ambulatory facilities. The state generates strong demand across joint replacement, sports medicine, spine, trauma, and extremity procedures. Its large working-age population also supports trauma and sports medicine demand, while population aging expands arthroplasty volumes.

Florida is a critical market because of its large older population. The state supports high volumes of hip and knee replacement, shoulder arthroplasty, fracture fixation, spine surgery, and revision procedures. Florida’s extensive ASC network makes it especially important for outpatient implant bundles, compact robotics, and technologies supporting same-day discharge.

North Carolina, Georgia, Tennessee, and Virginia are growing markets due to population expansion, specialist recruitment, and investment by regional health systems. North Carolina has influential academic orthopedic centers and a strong life sciences ecosystem. Tennessee contains major orthopedic companies and established physician networks, while Georgia and Virginia combine expanding metropolitan populations with high-volume hospital systems.

West Virginia, Kentucky, Mississippi, Alabama, Louisiana, Arkansas, and Oklahoma have elevated arthritis, obesity, disability, and chronic disease burdens. West Virginia has historically recorded one of the highest state-level arthritis prevalence rates in the country. These states generate significant need for joint reconstruction, trauma fixation, spine intervention, and mobility-restoring procedures, although rural access and workforce limitations can constrain advanced technology adoption outside major referral centers.

The South is expected to remain the largest regional market through 2035, reaching approximately USD 26.40 billion. Growth will be driven by population migration, outpatient arthroplasty, trauma demand, robotic penetration, hospital consolidation, and expansion of orthopedic specialty facilities.

West

The West represented an estimated USD 7.99 billion in 2025 and is projected to be the fastest-growing region. It includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the largest state market in the region. Its size is supported by a large population, major academic centers, sophisticated integrated health systems, high surgical volumes, and a strong medtech and digital health ecosystem. California providers are important adopters of robotics, patient-specific planning, advanced spine technologies, biologics, and ambulatory orthopedic surgery.

Arizona and Nevada are expanding rapidly because of population growth, retirement migration, and increasing demand for joint replacement and spine care. Arizona is becoming an important arthroplasty and outpatient surgery market, while Nevada’s growth is generating investment in specialty hospitals and ambulatory infrastructure.

Washington and Oregon have advanced integrated delivery networks that emphasize clinical evidence, care standardization, and digital integration. These states are attractive for connected procedure platforms, outcomes tracking, minimally invasive surgery, and enterprise-level procurement.

Colorado and Utah have strong orthopedic specialist networks, active populations, sports medicine demand, and innovation-oriented health systems. Their demographic profiles support a mix of trauma, arthroscopy, joint reconstruction, and spine procedures.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller markets with significant geographic access challenges. Regional referral centers play an outsized role in complex orthopedic care. Manufacturers can create value through reliable distribution, remote training, compact equipment, and systems suited to facilities serving broad rural catchment areas.

The West is expected to reach approximately USD 16.94 billion by 2035. Growth will be supported by advanced technology adoption, population expansion in the Mountain West, outpatient migration, and stronger integration of surgical planning, robotics, and data analytics.

Northeast

The Northeast accounted for approximately USD 7.65 billion in 2025. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Maine, New Hampshire, and Vermont.

New York is the largest state market in the Northeast because of its population, dense hospital infrastructure, trauma volume, academic centers, and specialist concentration. The state supports demand across arthroplasty, spine, sports medicine, extremity surgery, and complex revision procedures.

Pennsylvania and New Jersey contain large orthopedic provider networks and significant joint replacement volumes. Pennsylvania benefits from established academic systems and regional referral centers, while New Jersey has a dense ambulatory surgery market and strong commercial insurance base.

Massachusetts is strategically influential despite its smaller population. The state’s academic hospitals and research institutions frequently participate in clinical trials, implant evaluation, robotic surgery adoption, and outcomes research. Procurement decisions tend to require strong clinical evidence and economic justification.

Connecticut and Rhode Island have mature hospital systems and meaningful outpatient orthopedic activity. Maine, New Hampshire, and Vermont have older populations that support joint replacement and fracture demand, but lower population density can limit procedure volumes outside regional centers.

The Northeast is a high-value market for complex spine, revision arthroplasty, advanced shoulder reconstruction, patient-specific implants, and academic evidence generation. Growth is expected to be slower than in the South and West because of mature procedure penetration and lower population growth. Nevertheless, the region is projected to reach approximately USD 14.49 billion by 2035, supported by premium technology adoption and high procedure intensity.

Midwest

The Midwest represented an estimated USD 6.26 billion in 2025. The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois is the largest regional state market, supported by Chicago’s major academic institutions, trauma centers, community hospitals, and orthopedic practices. Ohio has a strong orthopedic care infrastructure and generates high demand across arthroplasty, spine, trauma, and sports medicine.

Michigan and Indiana provide large procedure bases and mature manufacturing or distribution networks. Wisconsin and Minnesota have established integrated health systems and influential orthopedic programs. Minnesota is particularly important because of its broader medical technology ecosystem and history of device innovation.

Missouri, Iowa, and Kansas support stable demand from community hospitals, regional referral centers, and ambulatory facilities. Nebraska, North Dakota, and South Dakota are smaller markets where rural access, travel distance, and specialist availability shape procedure patterns.

The Midwest has meaningful arthritis, obesity, and trauma burdens, but population growth is slower than in much of the South and West. Manufacturers typically compete through clinical service, reliable distribution, cost-effective contracting, surgeon education, and long-term relationships with integrated health systems.

The region is projected to reach approximately USD 12.16 billion by 2035. Growth will be steady rather than disruptive, with the strongest opportunities in outpatient arthroplasty, trauma fixation, robotic adoption outside major metropolitan centers, and simplified procedure systems for community hospitals.

 

Key Market Players

The U.S. Orthopedic Procedure Devices Competitive Landscape is consolidated in large-joint reconstruction and robotic surgery but remains fragmented across trauma, spine, extremities, orthobiologics, and specialized procedure technologies.

Competition is increasingly platform-based. Leading manufacturers combine implants, instruments, robotics, navigation, software, service, clinical education, and hospital contracting. Broad portfolios allow companies to bundle products across arthroplasty, trauma, spine, sports medicine, and ambulatory procedures. Smaller companies can still gain share by solving specific workflow problems, addressing underserved anatomy, or offering differentiated fixation and biologic technologies.

Some of the key players operating in the U.S. Orthopedic Procedure Devices industry are:

Stryker Corporation
Zimmer Biomet Holdings
DePuy Synthes, Johnson & Johnson MedTech
Smith+Nephew
Medtronic
Globus Medical
Enovis Corporation
Arthrex
CONMED Corporation
Aesculap, B. Braun
Integra LifeSciences
Orthofix Medical
Alphatec Holdings
ZimVie
Exactech
MicroPort Orthopedics
Acumed
Treace Medical Concepts
SI-BONE
Paragon 28
Bioventus
LifeNet Health
RTI Surgical
THINK Surgical
OSSIO

Stryker, Zimmer Biomet, DePuy Synthes, and Smith+Nephew hold particularly strong positions in large-joint reconstruction and enabling technologies. Stryker has developed a major competitive advantage through the Mako robotic ecosystem and its linked implant portfolio. Zimmer Biomet competes through ROSA robotics, broad knee and hip franchises, mixed-reality tools, and expanded autonomous robotics capabilities. DePuy Synthes combines reconstruction, trauma, spine, sports medicine, and the VELYS digital surgery platform. Smith+Nephew is differentiated through handheld CORI robotics, sports medicine, trauma, and shoulder reconstruction.

Medtronic, Globus Medical, Alphatec, Orthofix, and ZimVie are important in spine and enabling technologies. Arthrex and CONMED are influential in sports medicine and arthroscopy. Enovis, Acumed, Treace Medical, Paragon 28, and Exactech support growth in shoulder, foot and ankle, extremities, and reconstructive procedures. Bioventus, LifeNet Health, RTI Surgical, and OSSIO participate in orthobiologics, regenerative products, and advanced fixation.

Market share through 2035 will be influenced by FDA clearances, implant survivorship, robotic procedure adoption, surgeon training, ASC suitability, supply-chain reliability, clinical evidence, and contracting flexibility. Companies capable of reducing procedure variation, instrument burden, complications, and total episode cost will have the strongest ability to defend premium pricing.

 

Recent Developments

Recent developments in the U.S. Orthopedic Procedure Devices Market show that orthopedic robotics is entering a more competitive and flexible phase. In July 2026, Stryker announced the U.S. commercial launch of its Mako Robotic Power System for total knee replacement. The handheld system combines intraoperative planning with robotically enabled cutting and is intended to extend Mako technology to providers seeking a different footprint and workflow from conventional robotic-arm platforms.

Smith+Nephew completed the first clinical cases using its next-generation CORI XT handheld robotic platform across knee and shoulder arthroplasty in 2026. The platform is designed for use across partial knee, total knee, revision knee, and shoulder applications. Its compact format reflects increasing industry focus on technologies that can operate effectively in both hospitals and ambulatory surgery centers.

Zimmer Biomet completed its acquisition of Monogram Technologies in October 2025. Monogram developed a CT-based, semi-autonomous, AI-navigated robotic technology for total knee arthroplasty that received FDA clearance in March 2025. The acquisition gives Zimmer Biomet a development pathway toward both semi-autonomous and fully autonomous orthopedic robotics, complementing its existing ROSA, mixed-reality, and navigation portfolio.

Johnson & Johnson MedTech expanded the clinical application of the VELYS Robotic-Assisted Solution after receiving FDA clearance for unicompartmental knee arthroplasty in 2024. The expansion illustrates how established robotic platforms are moving beyond total knee replacement into partial knee procedures and broader procedural ecosystems.

Robotic shoulder arthroplasty is also becoming a new competitive frontier. Shoulder surgery requires accurate management of complex anatomy and implant positioning, making it suitable for preoperative 3D planning and guided bone preparation. The entry of robotic shoulder applications is expected to increase competition among implant manufacturers and enabling-technology companies.

Enovis expanded its bone-healing portfolio in 2025 through the launch of a low-intensity pulsed ultrasound bone growth stimulation system. The development reflects growing interest in technologies that extend orthopedic device participation beyond the operating room into fracture healing, nonunion management, and longitudinal recovery.

The market is also being shaped by consolidation. Large orthopedic manufacturers are acquiring robotics, extremity, foot and ankle, biologic, and surgical planning capabilities to create broader procedure platforms. Acquisitions can increase implant pull-through and accelerate commercialization, but they also create integration challenges involving sales forces, product portfolios, surgeon relationships, and information systems.

Hospital purchasing strategies are evolving in response. Providers are becoming less willing to acquire multiple isolated robotic systems without a clear utilization plan. Procurement committees increasingly favor platforms that support multiple procedures, fit ASC workflows, integrate with existing implants, and provide measurable clinical or operational value.

 

Conclusion

The U.S. Orthopedic Procedure Devices Market Size & Share is positioned to expand from USD 34.76 billion in 2025 to USD 69.99 billion by 2035, representing a CAGR of 7.25% during 2026–2035. The market’s long-term strength is supported by population aging, arthritis prevalence, trauma demand, outpatient surgery expansion, and increasing investment in procedure-enabling technologies.

Joint reconstruction will remain the largest device category, but the fastest value creation is expected in robotic-assisted surgery, navigation, patient-specific planning, shoulder reconstruction, extremity procedures, biologically integrated fixation, minimally invasive spine systems, and technologies designed specifically for ambulatory facilities.

The industry will increasingly be defined by complete procedure economics. Hospitals and ASCs will evaluate whether a device reduces operating room time, lowers instrument and sterilization requirements, supports predictable discharge, limits complications, and improves patient-reported outcomes. Clinical differentiation without workflow or economic value will become more difficult to commercialize.

Regional opportunity will be led by the South due to its population scale, aging demographics, chronic disease burden, and expanding healthcare infrastructure. The West will record the fastest growth because of technology adoption and population expansion. The Northeast will remain strategically important for complex procedures, premium devices, and evidence generation, while the Midwest will provide stable demand through established orthopedic networks and community hospital systems.

At the state level, Texas, Florida, California, New York, Pennsylvania, Ohio, Illinois, North Carolina, Georgia, Arizona, Michigan, Massachusetts, Tennessee, Virginia, and New Jersey will remain especially important markets for manufacturers, distributors, investors, and healthcare providers.

For clients evaluating this industry, the central strategic question is not simply how many orthopedic procedures will be performed. The more important questions concern where procedures will migrate, which technologies will become economically sustainable, how health systems will standardize vendors, and which companies can connect implants, instruments, enabling technologies, and outcomes into a coherent platform.

Companies that combine differentiated clinical technology with procedural efficiency, ASC-compatible economics, strong reimbursement support, reliable supply, and defensible real-world evidence will be best positioned to shape the next decade of the U.S. orthopedic procedure devices industry.

 

TABLE OF CONTENT

1. U.S. Orthopedic Procedure Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Orthopedic Implant and Procedure Device Manufacturers
1.6.2. Surgical Instrument and Power Tool Manufacturers
1.6.3. Component, Biomaterial, and Contract Manufacturing Suppliers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Orthopedic Specialty Hospitals and Academic Medical Centers
1.6.6. Ambulatory Surgery Centers and Orthopedic Practices
1.6.7. Group Purchasing Organizations, Distributors, and Specialty Dealers
1.6.8. Orthopedic Surgeons and Perioperative Clinical Teams
1.6.9. Payers, Regulators, and Value Analysis Committees

What this section provides: This section establishes the market definition, inclusion and exclusion criteria, study scope, research methodology, assumptions, and stakeholder ecosystem used to measure and validate the U.S. orthopedic procedure devices market.

2. U.S. Orthopedic Procedure Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size and CAGR Assessment
2.8. Leading Device Category
2.9. Fastest-Growing Procedure Type
2.10. Highest-Growth Technology Platform
2.11. Leading End-User Setting
2.12. Regional Market Leadership
2.13. High-Growth Opportunity Areas

What this section provides: This section gives decision-makers a concise overview of market size, historical development, forecast growth, category leadership, regional positioning, competitive intensity, and priority commercial opportunities.

3. U.S. Orthopedic Procedure Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Prevalence of Osteoarthritis and Degenerative Joint Disease
3.1.2. Expansion of the U.S. Population Aged 65 and Older
3.1.3. Increasing Joint Replacement and Revision Procedure Volumes
3.1.4. Growth in Sports Injuries and Soft-Tissue Repair Procedures
3.1.5. Rising Orthopedic Trauma and Fragility Fracture Burden
3.1.6. Migration of Orthopedic Procedures to Outpatient Settings
3.1.7. Adoption of Robotic-Assisted and Navigated Orthopedic Surgery
3.1.8. Demand for Minimally Invasive Spine and Extremity Procedures
3.1.9. Growth in Cementless, Porous, and Biologically Integrated Implants
3.1.10. Increased Focus on Implant Survivorship and Revision Reduction
3.2. Restraints and Their Impact Analysis
3.2.1. High Implant, Instrument, and Robotic Platform Costs
3.2.2. Reimbursement Pressure and Bundled Payment Exposure
3.2.3. Hospital Value Analysis and Vendor Standardization Pressure
3.2.4. Product Recalls, Implant Failure, and Litigation Risk
3.2.5. Surgical Workforce and Operating Room Capacity Constraints
3.2.6. Limited Access to Advanced Orthopedic Care in Rural Areas
3.2.7. Capital Budget Constraints among Community Hospitals and ASCs
3.3. Opportunities and Their Impact Analysis
3.3.1. Robotic-Assisted Knee, Hip, Shoulder, and Spine Procedures
3.3.2. Expansion of Outpatient Joint Replacement
3.3.3. Patient-Specific Surgical Planning and Instrumentation
3.3.4. Three-Dimensional Printed and Customized Implants
3.3.5. Cementless Joint Reconstruction Systems
3.3.6. Minimally Invasive and Endoscopic Spine Procedures
3.3.7. Foot and Ankle, Shoulder, and Small-Joint Reconstruction
3.3.8. Orthobiologics and Bone-Healing Technologies
3.3.9. Smart Instruments and Sensor-Enabled Orthopedic Platforms
3.3.10. Sterile-Packed Implants and Procedure-Specific Kits
3.4. Challenges and Their Impact Analysis
3.4.1. Surgeon Preference and Product Conversion Barriers
3.4.2. Instrument Tray and Sterilization Complexity
3.4.3. Implant Inventory and Consignment Management
3.4.4. Procedure Variability and Patient Selection Risk
3.4.5. Clinical Evidence Requirements for Premium Technologies
3.4.6. Supply-Chain Dependence on Specialty Metals and Polymers
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Orthopedic Clinical Workflow Economics Analysis
3.7. Operating Room Efficiency and Instrument Utilization Analysis
3.8. Hospital Capital Procurement Behavior Analysis
3.9. Ambulatory Surgery Center Procedure Economics Analysis
3.10. Orthopedic Implant Price Benchmarking Framework
3.11. Patient-Reported Outcome and Revision-Risk Analysis

What this section provides: This section explains the demographic, clinical, procedural, reimbursement, operational, and procurement forces shaping orthopedic device demand, helping clients evaluate growth opportunities and execution risks.

4. U.S. Orthopedic Procedure Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.4.1. Raw Material and Biomaterial Suppliers
4.4.2. Precision Component Manufacturers
4.4.3. Implant and Instrument Manufacturers
4.4.4. Sterilization and Packaging Providers
4.4.5. Distributors and Specialty Sales Representatives
4.4.6. Hospitals, ASCs, and Orthopedic Practices
4.5. Orthopedic Device Manufacturing Ecosystem
4.6. Surgical Instrument and Implant Inventory Management
4.7. Impact of Digitalization and Connected Orthopedic Surgery
4.8. Application & Innovation Landscape
4.9. FDA Regulatory Framework Analysis
4.9.1. Class I Orthopedic Procedure Devices
4.9.2. Class II Orthopedic Procedure Devices
4.9.3. Class III Orthopedic Implants
4.9.4. 510(k) Premarket Notification Pathway
4.9.5. Premarket Approval Pathway
4.9.6. Humanitarian and Breakthrough Device Considerations
4.10. CMS Reimbursement and Coverage Landscape
4.10.1. Inpatient Prospective Payment System
4.10.2. Hospital Outpatient Prospective Payment System
4.10.3. Ambulatory Surgical Center Payment Framework
4.10.4. Bundled Payment and Episode-Based Reimbursement
4.10.5. Patient-Reported Outcome Reporting Requirements
4.11. Import/Export Restrictions & Tariff Impact
4.12. Government Initiatives and Musculoskeletal Health Programs
4.13. Impact of Escalating Geopolitical Tensions
4.14. Hospital Value Analysis Committee Decision Framework
4.15. Group Purchasing Organization Contracting Analysis
4.16. Orthopedic Device Recall and Post-Market Surveillance Analysis
4.17. Environmental Impact of Reusable and Single-Use Instruments

What this section provides: This section gives clients a complete view of the regulatory, reimbursement, pricing, manufacturing, supply-chain, digitalization, procurement, and competitive environment surrounding orthopedic procedure devices.

5. U.S. Orthopedic Procedure Devices Market – By Device Category

5.1. Overview
5.1.1. Segment Share Analysis, By Device Category, 2025 & 2035 (%)
5.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)
5.2. Joint Reconstruction Devices
5.2.1. Knee Reconstruction Devices
5.2.1.1. Total Knee Replacement Systems
5.2.1.2. Partial Knee Replacement Systems
5.2.1.3. Patellofemoral Replacement Systems
5.2.1.4. Revision Knee Systems
5.2.1.5. Cemented Knee Implants
5.2.1.6. Cementless Knee Implants
5.2.2. Hip Reconstruction Devices
5.2.2.1. Total Hip Replacement Systems
5.2.2.2. Partial Hip and Hemiarthroplasty Systems
5.2.2.3. Hip Resurfacing Systems
5.2.2.4. Revision Hip Systems
5.2.2.5. Dual-Mobility Hip Systems
5.2.2.6. Cemented and Cementless Hip Implants
5.2.3. Shoulder Reconstruction Devices
5.2.3.1. Anatomic Shoulder Replacement Systems
5.2.3.2. Reverse Shoulder Replacement Systems
5.2.3.3. Shoulder Hemiarthroplasty Systems
5.2.3.4. Revision Shoulder Systems
5.2.4. Ankle, Elbow, Wrist, and Small-Joint Implants
5.3. Trauma Fixation Devices
5.3.1. Bone Plates
5.3.2. Bone Screws
5.3.3. Intramedullary Nails
5.3.4. Pins and Wires
5.3.5. External Fixation Systems
5.3.6. Pelvic and Acetabular Fixation Systems
5.3.7. Craniofacial and Small-Bone Fixation Systems
5.3.8. Sterile-Packed Trauma Implants
5.4. Spine Procedure Devices
5.4.1. Pedicle Screw and Rod Systems
5.4.2. Interbody Fusion Devices
5.4.3. Cervical Plates and Fixation Systems
5.4.4. Artificial Disc Replacement Devices
5.4.5. Expandable Cages and Corpectomy Systems
5.4.6. Vertebral Augmentation Devices
5.4.7. Minimally Invasive Spine Systems
5.4.8. Spine Biologics and Fusion Adjuncts
5.5. Sports Medicine and Arthroscopy Devices
5.5.1. Suture Anchors
5.5.2. Interference Screws
5.5.3. Meniscal Repair Systems
5.5.4. Ligament Reconstruction Systems
5.5.5. Tendon Repair Devices
5.5.6. Graft Preparation Systems
5.5.7. Arthroscopes and Visualization Systems
5.5.8. Shavers, Pumps, and Fluid-Management Systems
5.5.9. Radiofrequency and Tissue Ablation Devices
5.6. Extremity Procedure Devices
5.6.1. Foot and Ankle Reconstruction Devices
5.6.2. Hand and Wrist Procedure Devices
5.6.3. Elbow Procedure Devices
5.6.4. Small-Joint Replacement Devices
5.6.5. Bunion and Deformity Correction Systems
5.6.6. Extremity Fusion and Fixation Devices
5.7. Orthopedic Instruments and Power Tools
5.7.1. Powered Drills and Saws
5.7.2. Reamers and Broaches
5.7.3. Manual Instrument Sets
5.7.4. Cutting Blocks and Alignment Guides
5.7.5. Arthroscopic Handpieces and Shavers
5.7.6. Batteries, Consoles, Blades, and Burs
5.8. Orthobiologic and Bone-Healing Devices
5.8.1. Bone Graft Substitutes
5.8.2. Demineralized Bone Matrix
5.8.3. Cellular Bone Matrices
5.8.4. Synthetic Bone Graft Materials
5.8.5. Bone Growth Stimulation Devices
5.8.6. Biologic Scaffolds and Soft-Tissue Augmentation Products

What this section provides: This section identifies the orthopedic device categories expected to generate the highest revenue contribution, procedure pull-through, replacement demand, and growth through 2035.

6. U.S. Orthopedic Procedure Devices Market – By Procedure Type

6.1. Overview
6.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2035 (%)
6.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)
6.2. Joint Arthroplasty
6.2.1. Total Knee Arthroplasty
6.2.2. Partial Knee Arthroplasty
6.2.3. Total Hip Arthroplasty
6.2.4. Hip Hemiarthroplasty
6.2.5. Shoulder Arthroplasty
6.2.6. Ankle and Small-Joint Arthroplasty
6.3. Fracture Fixation and Trauma Reconstruction
6.3.1. Upper-Extremity Fracture Fixation
6.3.2. Lower-Extremity Fracture Fixation
6.3.3. Hip Fracture Fixation
6.3.4. Pelvic and Acetabular Reconstruction
6.3.5. External Fixation Procedures
6.3.6. Fragility-Fracture Procedures
6.4. Spinal Fusion, Decompression, and Stabilization
6.4.1. Cervical Fusion Procedures
6.4.2. Lumbar Fusion Procedures
6.4.3. Spinal Decompression Procedures
6.4.4. Disc Replacement Procedures
6.4.5. Spinal Deformity Correction
6.4.6. Vertebral Augmentation Procedures
6.4.7. Minimally Invasive Spine Procedures
6.5. Arthroscopy and Soft-Tissue Repair
6.5.1. Anterior Cruciate Ligament Reconstruction
6.5.2. Meniscal Repair
6.5.3. Rotator Cuff Repair
6.5.4. Labral Repair
6.5.5. Cartilage Restoration Procedures
6.5.6. Tendon and Ligament Reconstruction
6.6. Extremity Reconstruction and Corrective Procedures
6.6.1. Foot and Ankle Reconstruction
6.6.2. Bunion and Forefoot Correction
6.6.3. Hand and Wrist Reconstruction
6.6.4. Elbow Reconstruction
6.6.5. Small-Joint Replacement
6.6.6. Extremity Fusion Procedures
6.7. Revision and Salvage Procedures
6.7.1. Revision Knee Arthroplasty
6.7.2. Revision Hip Arthroplasty
6.7.3. Revision Shoulder Arthroplasty
6.7.4. Revision Spine Surgery
6.7.5. Failed Fixation and Nonunion Procedures
6.7.6. Periprosthetic Joint Infection Procedures
6.7.7. Complex Bone-Loss Reconstruction

What this section provides: This section helps clients assess demand by orthopedic procedure, identify high-volume and high-value interventions, and prioritize procedure areas benefiting from outpatient migration and technology adoption.

7. U.S. Orthopedic Procedure Devices Market – By Anatomical Site

7.1. Overview
7.1.1. Segment Share Analysis, By Anatomical Site, 2025 & 2035 (%)
7.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)
7.2. Knee
7.2.1. Knee Replacement
7.2.2. Knee Arthroscopy
7.2.3. Ligament and Meniscal Repair
7.2.4. Knee Trauma Fixation
7.2.5. Knee Revision Procedures
7.3. Hip and Pelvis
7.3.1. Hip Replacement
7.3.2. Hip Fracture Fixation
7.3.3. Pelvic and Acetabular Reconstruction
7.3.4. Hip Arthroscopy
7.3.5. Hip Revision Procedures
7.4. Spine
7.4.1. Cervical Spine
7.4.2. Thoracic Spine
7.4.3. Lumbar Spine
7.4.4. Sacroiliac Joint
7.4.5. Spinal Deformity and Revision Procedures
7.5. Shoulder
7.5.1. Shoulder Arthroplasty
7.5.2. Rotator Cuff Repair
7.5.3. Labral Repair
7.5.4. Shoulder Fracture Fixation
7.5.5. Shoulder Revision Procedures
7.6. Foot and Ankle
7.6.1. Foot and Ankle Trauma
7.6.2. Bunion Correction
7.6.3. Ankle Fusion
7.6.4. Total Ankle Replacement
7.6.5. Tendon and Ligament Repair
7.7. Hand and Wrist
7.7.1. Hand and Wrist Fracture Fixation
7.7.2. Small-Joint Replacement
7.7.3. Ligament and Tendon Repair
7.7.4. Fusion and Corrective Procedures
7.8. Elbow
7.8.1. Elbow Arthroplasty
7.8.2. Elbow Fracture Fixation
7.8.3. Ligament and Tendon Reconstruction
7.9. Other Anatomical Sites

What this section provides: This section evaluates orthopedic procedure demand by anatomical site, helping clients identify the joints and body regions generating the strongest implant, instrument, and enabling-technology requirements.

8. U.S. Orthopedic Procedure Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)
8.2. Conventional Manual Procedure Systems
8.2.1. Standard Manual Instruments
8.2.2. Conventional Cutting and Alignment Guides
8.2.3. Reusable Instrument Trays
8.2.4. Manual Implant Preparation Systems
8.3. Powered Surgical Technologies
8.3.1. Battery-Powered Surgical Instruments
8.3.2. Pneumatic Surgical Instruments
8.3.3. Electric Surgical Instruments
8.3.4. Powered Arthroscopy Systems
8.3.5. Powered Bone Preparation Systems
8.4. Minimally Invasive and Arthroscopic Technologies
8.4.1. Arthroscopic Visualization
8.4.2. Percutaneous Fixation Systems
8.4.3. Minimally Invasive Spine Platforms
8.4.4. Endoscopic Orthopedic Procedure Systems
8.4.5. Small-Incision Joint Reconstruction Systems
8.5. Navigation and Robotic-Assisted Technologies
8.5.1. Robotic-Arm Assisted Systems
8.5.2. Handheld Robotic Systems
8.5.3. Computer-Assisted Navigation Systems
8.5.4. Imageless Navigation Systems
8.5.5. CT-Based Robotic Systems
8.5.6. Semi-Autonomous Robotic Systems
8.5.7. Multi-Procedure Orthopedic Robotic Platforms
8.6. Patient-Specific and Three-Dimensional Technologies
8.6.1. Patient-Specific Surgical Planning
8.6.2. Patient-Specific Cutting Guides
8.6.3. Customized Orthopedic Implants
8.6.4. Additively Manufactured Implants
8.6.5. Porous and Trabecular Implant Structures
8.7. Smart, Sensor-Enabled, and AI-Assisted Technologies
8.7.1. AI-Assisted Preoperative Planning
8.7.2. Intraoperative Sensor Technologies
8.7.3. Smart Surgical Instruments
8.7.4. Connected Orthopedic Platforms
8.7.5. Mixed-Reality and Augmented-Reality Guidance
8.7.6. Postoperative Monitoring and Outcomes Analytics

What this section provides: This section evaluates the technologies reshaping orthopedic procedures, including manual systems, power tools, minimally invasive platforms, robotics, navigation, 3D printing, sensors, and AI-assisted workflows.

9. U.S. Orthopedic Procedure Devices Market – By End User

9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
9.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)
9.2. Hospitals and Integrated Health Systems
9.2.1. Large Integrated Delivery Networks
9.2.2. Community Hospitals
9.2.3. Regional Referral Hospitals
9.2.4. Level I and Level II Trauma Centers
9.3. Ambulatory Surgery Centers
9.3.1. Independent Orthopedic ASCs
9.3.2. Hospital-Owned ASCs
9.3.3. Surgeon-Owned ASCs
9.3.4. Multi-Specialty ASCs
9.4. Orthopedic Specialty Hospitals and Clinics
9.4.1. Orthopedic Specialty Hospitals
9.4.2. Joint Replacement Centers
9.4.3. Spine Centers
9.4.4. Sports Medicine Centers
9.4.5. Foot and Ankle Clinics
9.5. Academic Medical Centers
9.5.1. Teaching Hospitals
9.5.2. Clinical Research Institutions
9.5.3. Orthopedic Training and Fellowship Centers
9.6. Community and Rural Providers
9.6.1. Rural Hospitals
9.6.2. Critical Access Hospitals
9.6.3. Regional Orthopedic Practices
9.6.4. Mobile and Visiting Surgical Programs

What this section provides: This section explains which care settings are expected to drive orthopedic device purchasing, procedure migration, implant utilization, capital investment, and recurring disposable demand.

10. U.S. Orthopedic Procedure Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Orthopedic Procedure Volume Analysis
10.1.4. Regional Hospital and ASC Infrastructure Analysis
10.1.5. Regional Musculoskeletal Disease and Demographic Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Robotics and Navigation Adoption Analysis
10.1.8. Regional Implant Pricing and Vendor Standardization Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Orthopedic Procedure Device Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Orthopedic Procedure Device Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Orthopedic Procedure Device Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Orthopedic Procedure Device Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Anatomical Site, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify orthopedic procedure-volume hubs, arthritis and aging-related demand centers, robotics adoption hotspots, ASC growth markets, and state-level commercial opportunities.

11. U.S. Orthopedic Procedure Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking
11.3.1. Joint Reconstruction Portfolio Strength
11.3.2. Trauma and Extremity Portfolio Strength
11.3.3. Spine Portfolio Strength
11.3.4. Sports Medicine Portfolio Strength
11.3.5. Robotics and Navigation Capabilities
11.3.6. Ambulatory Surgery Center Strategy
11.3.7. Clinical Evidence and Surgeon Education
11.3.8. U.S. Distribution and Service Coverage
11.4. Company Profiles
11.4.1. Stryker Corporation
11.4.2. Zimmer Biomet Holdings, Inc.
11.4.3. DePuy Synthes, Johnson & Johnson MedTech
11.4.4. Smith+Nephew plc
11.4.5. Medtronic plc
11.4.6. Globus Medical, Inc.
11.4.7. Enovis Corporation
11.4.8. Arthrex, Inc.
11.4.9. CONMED Corporation
11.4.10. Aesculap, Inc., B. Braun
11.4.11. Integra LifeSciences Holdings Corporation
11.4.12. Orthofix Medical Inc.
11.4.13. Alphatec Holdings, Inc.
11.4.14. ZimVie Inc.
11.4.15. Exactech, Inc.
11.4.16. MicroPort Orthopedics Inc.
11.4.17. Acumed LLC
11.4.18. Treace Medical Concepts, Inc.
11.4.19. SI-BONE, Inc.
11.4.20. Paragon 28, Inc.
11.4.21. Bioventus Inc.
11.4.22. LifeNet Health
11.4.23. RTI Surgical, Inc.
11.4.24. THINK Surgical, Inc.
11.4.25. OSSIO Ltd.

Note: Each company profile will include company overview, orthopedic procedure device portfolio, U.S. market strategy, financial positioning, clinical and innovation pipeline, regulatory developments, partnerships, acquisitions, distribution strategy, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market share visibility, portfolio positioning, robotic and digital capability analysis, innovation direction, and strategic intelligence on leading orthopedic procedure device companies.

12. U.S. Orthopedic Procedure Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Robotic-Assisted Joint Replacement
12.2.2. Handheld and Portable Orthopedic Robotics
12.2.3. Semi-Autonomous and Autonomous Surgical Platforms
12.2.4. AI-Assisted Surgical Planning
12.2.5. Three-Dimensional Printed and Customized Implants
12.2.6. Smart Implants and Sensor-Enabled Instruments
12.2.7. Mixed-Reality and Augmented-Reality Guidance
12.2.8. Minimally Invasive and Endoscopic Spine Systems
12.2.9. Orthobiologics and Bone-Regeneration Technologies
12.2.10. Connected Recovery and Outcomes-Monitoring Platforms
12.3. Emerging Business Trends
12.3.1. Outpatient Joint Replacement Expansion
12.3.2. Multi-Procedure Robotic Platform Adoption
12.3.3. Procedure-Based Pricing and Capital Placement Models
12.3.4. Implant Bundling and Enterprise Vendor Standardization
12.3.5. Sterile-Packed and Single-Use Instrument Adoption
12.3.6. Surgeon-Owned ASC Procurement Growth
12.3.7. Data-Linked Implant Contracting
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Market White-Space Analysis
12.7. Technology Adoption Curve, 2026–2035
12.8. Future Orthopedic Procedure Site-of-Care Analysis

What this section provides: This section prepares clients for future technology shifts, procedure migration, competitive restructuring, investment opportunities, and alternative orthopedic device adoption scenarios through 2035.

13. U.S. Orthopedic Procedure Devices Market: Strategic Recommendations

13.1. Recommendations for Orthopedic Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Ambulatory Surgery Centers
13.4. Recommendations for Orthopedic Surgeons and Specialty Practices
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. Robotic and Digital Platform Commercialization Strategy
13.11. Ambulatory Surgery Center Market-Entry Strategy
13.12. Clinical Evidence and Health Economic Evidence Strategy
13.13. Pricing, Contracting, and Vendor Standardization Strategy
13.14. State-Level Commercial Prioritization Strategy
13.15. Merger, Acquisition, and Partnership Opportunity Assessment

What this section provides: This section converts market intelligence into actionable recommendations for growth planning, product development, evidence generation, channel expansion, investment decisions, contracting, and competitive differentiation.

14. U.S. Orthopedic Procedure Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Market Estimation and Rounding Disclaimer
14.7. Company and Product Information Disclaimer
14.8. Regulatory and Reimbursement Disclaimer

What this section provides: This section clarifies the report’s scope limitations, forecasting assumptions, legal boundaries, data-use terms, market-estimation methodology, and third-party information limitations.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Orthopedic Procedure Devices Market: Market Definition and Scope
TABLE 3: U.S. Orthopedic Procedure Devices Market: Research Methodology Framework
TABLE 4: U.S. Orthopedic Procedure Devices Market: Key Assumptions
TABLE 5: U.S. Orthopedic Procedure Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Orthopedic Procedure Devices Market: Stakeholder Analysis
TABLE 7: U.S. Orthopedic Procedure Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Orthopedic Procedure Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Orthopedic Procedure Devices Market: Market Attractiveness Index
TABLE 10: U.S. Orthopedic Procedure Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Orthopedic Procedure Devices Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Orthopedic Procedure Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Orthopedic Procedure Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 14: U.S. Orthopedic Procedure Devices Market: High-Growth Opportunity Areas
TABLE 15: U.S. Orthopedic Procedure Devices Market: Drivers; Impact Analysis
TABLE 16: U.S. Orthopedic Procedure Devices Market: Restraints; Impact Analysis
TABLE 17: U.S. Orthopedic Procedure Devices Market: Opportunities; Impact Analysis
TABLE 18: U.S. Orthopedic Procedure Devices Market: Challenges; Impact Analysis
TABLE 19: U.S. Orthopedic Procedure Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Orthopedic Procedure Devices Market: Orthopedic Clinical Workflow Economics Matrix
TABLE 21: U.S. Orthopedic Procedure Devices Market: Operating Room Efficiency and Instrument Utilization Matrix
TABLE 22: U.S. Orthopedic Procedure Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 23: U.S. Orthopedic Procedure Devices Market: Ambulatory Surgery Center Procedure Economics Matrix
TABLE 24: U.S. Orthopedic Procedure Devices Market: Implant Price Benchmarking Framework
TABLE 25: U.S. Orthopedic Procedure Devices Market: Patient-Reported Outcome and Revision-Risk Analysis
TABLE 26: U.S. Orthopedic Procedure Devices Market: PESTEL Analysis
TABLE 27: U.S. Orthopedic Procedure Devices Market: Porter’s Five Forces Analysis
TABLE 28: U.S. Orthopedic Procedure Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 29: U.S. Orthopedic Procedure Devices Market: Value Chain Analysis
TABLE 30: U.S. Orthopedic Procedure Devices Market: Supply Chain Analysis
TABLE 31: U.S. Orthopedic Procedure Devices Market: Orthopedic Device Manufacturing Ecosystem
TABLE 32: U.S. Orthopedic Procedure Devices Market: Surgical Instrument and Implant Inventory Management
TABLE 33: U.S. Orthopedic Procedure Devices Market: Digitalization and Connected Orthopedic Surgery Impact
TABLE 34: U.S. Orthopedic Procedure Devices Market: Application & Innovation Landscape
TABLE 35: U.S. Orthopedic Procedure Devices Market: FDA Regulatory Framework Analysis
TABLE 36: U.S. Orthopedic Procedure Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 37: U.S. Orthopedic Procedure Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 38: U.S. Orthopedic Procedure Devices Market: Government Initiatives and Musculoskeletal Health Programs
TABLE 39: U.S. Orthopedic Procedure Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 40: U.S. Orthopedic Procedure Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 41: U.S. Orthopedic Procedure Devices Market: Group Purchasing Organization Contracting Analysis
TABLE 42: U.S. Orthopedic Procedure Devices Market: Recall and Post-Market Surveillance Analysis
TABLE 43: U.S. Orthopedic Procedure Devices Market: Environmental Impact of Reusable and Single-Use Instruments
TABLE 44: U.S. Orthopedic Procedure Devices Market: Device Category Snapshot, 2025
TABLE 45: Segment Dashboard; Definition and Scope, by Device Category
TABLE 46: U.S. Orthopedic Procedure Devices Market, by Device Category, 2021–2035 (US$ Billion)
TABLE 47: U.S. Orthopedic Procedure Devices Market: Segment Share Analysis, by Device Category, 2025 & 2035 (%)
TABLE 48: U.S. Orthopedic Procedure Devices Market: Joint Reconstruction Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Orthopedic Procedure Devices Market: Trauma Fixation Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Orthopedic Procedure Devices Market: Spine Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Orthopedic Procedure Devices Market: Sports Medicine and Arthroscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Orthopedic Procedure Devices Market: Extremity Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Orthopedic Procedure Devices Market: Orthopedic Instruments and Power Tools Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Orthopedic Procedure Devices Market: Orthobiologic and Bone-Healing Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Orthopedic Procedure Devices Market: Procedure Type Snapshot, 2025
TABLE 56: Segment Dashboard; Definition and Scope, by Procedure Type
TABLE 57: U.S. Orthopedic Procedure Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 58: U.S. Orthopedic Procedure Devices Market: Segment Share Analysis, by Procedure Type, 2025 & 2035 (%)
TABLE 59: U.S. Orthopedic Procedure Devices Market: Joint Arthroplasty Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Orthopedic Procedure Devices Market: Fracture Fixation and Trauma Reconstruction Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Orthopedic Procedure Devices Market: Spinal Fusion, Decompression, and Stabilization Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Orthopedic Procedure Devices Market: Arthroscopy and Soft-Tissue Repair Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Orthopedic Procedure Devices Market: Extremity Reconstruction and Corrective Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Orthopedic Procedure Devices Market: Revision and Salvage Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Orthopedic Procedure Devices Market: Anatomical Site Snapshot, 2025
TABLE 66: Segment Dashboard; Definition and Scope, by Anatomical Site
TABLE 67: U.S. Orthopedic Procedure Devices Market, by Anatomical Site, 2021–2035 (US$ Billion)
TABLE 68: U.S. Orthopedic Procedure Devices Market: Segment Share Analysis, by Anatomical Site, 2025 & 2035 (%)
TABLE 69: U.S. Orthopedic Procedure Devices Market: Knee Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Orthopedic Procedure Devices Market: Hip and Pelvis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Orthopedic Procedure Devices Market: Spine Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Orthopedic Procedure Devices Market: Shoulder Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Orthopedic Procedure Devices Market: Foot and Ankle Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Orthopedic Procedure Devices Market: Hand and Wrist Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Orthopedic Procedure Devices Market: Elbow Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Orthopedic Procedure Devices Market: Other Anatomical Sites Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Orthopedic Procedure Devices Market: Technology Type Snapshot, 2025
TABLE 78: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 79: U.S. Orthopedic Procedure Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 80: U.S. Orthopedic Procedure Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 81: U.S. Orthopedic Procedure Devices Market: Conventional Manual Procedure Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Orthopedic Procedure Devices Market: Powered Surgical Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Orthopedic Procedure Devices Market: Minimally Invasive and Arthroscopic Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Orthopedic Procedure Devices Market: Navigation and Robotic-Assisted Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Orthopedic Procedure Devices Market: Patient-Specific and Three-Dimensional Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Orthopedic Procedure Devices Market: Smart, Sensor-Enabled, and AI-Assisted Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. Orthopedic Procedure Devices Market: End User Snapshot, 2025
TABLE 88: Segment Dashboard; Definition and Scope, by End User
TABLE 89: U.S. Orthopedic Procedure Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 90: U.S. Orthopedic Procedure Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 91: U.S. Orthopedic Procedure Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: U.S. Orthopedic Procedure Devices Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: U.S. Orthopedic Procedure Devices Market: Orthopedic Specialty Hospitals and Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: U.S. Orthopedic Procedure Devices Market: Academic Medical Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: U.S. Orthopedic Procedure Devices Market: Community and Rural Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: U.S. Orthopedic Procedure Devices Market: Regional Snapshot, 2025
TABLE 97: Segment Dashboard; Definition and Scope, by Geography
TABLE 98: U.S. Orthopedic Procedure Devices Market, by Geography, 2021–2035 (US$ Billion)
TABLE 99: U.S. Orthopedic Procedure Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 100: U.S. Orthopedic Procedure Devices Market: Regional Orthopedic Procedure Volume Analysis
TABLE 101: U.S. Orthopedic Procedure Devices Market: Regional Hospital and ASC Infrastructure Analysis
TABLE 102: U.S. Orthopedic Procedure Devices Market: Regional Musculoskeletal Disease and Demographic Analysis
TABLE 103: U.S. Orthopedic Procedure Devices Market: Regional Reimbursement and Procurement Dynamics
TABLE 104: U.S. Orthopedic Procedure Devices Market: Regional Robotics and Navigation Adoption Analysis
TABLE 105: U.S. Orthopedic Procedure Devices Market: Regional Implant Pricing and Vendor Standardization Analysis
TABLE 106: West Region U.S. Orthopedic Procedure Devices Market: Regional Overview and Trends
TABLE 107: West Region U.S. Orthopedic Procedure Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 108: West Region U.S. Orthopedic Procedure Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 109: West Region U.S. Orthopedic Procedure Devices Market, by Device Category, 2021–2035 (US$ Billion)
TABLE 110: West Region U.S. Orthopedic Procedure Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 111: West Region U.S. Orthopedic Procedure Devices Market, by Anatomical Site, 2021–2035 (US$ Billion)
TABLE 112: West Region U.S. Orthopedic Procedure Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 113: West Region U.S. Orthopedic Procedure Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 114: California Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Washington Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Arizona Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Colorado Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Oregon Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Utah Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: Nevada Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: New Mexico Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: Idaho Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Montana Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Wyoming Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Alaska Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Hawaii Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Northeast Region U.S. Orthopedic Procedure Devices Market: Regional Overview and Trends
TABLE 128: Northeast Region U.S. Orthopedic Procedure Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 129: Northeast Region U.S. Orthopedic Procedure Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 130: Northeast Region U.S. Orthopedic Procedure Devices Market, by Device Category, 2021–2035 (US$ Billion)
TABLE 131: Northeast Region U.S. Orthopedic Procedure Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 132: Northeast Region U.S. Orthopedic Procedure Devices Market, by Anatomical Site, 2021–2035 (US$ Billion)
TABLE 133: Northeast Region U.S. Orthopedic Procedure Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 134: Northeast Region U.S. Orthopedic Procedure Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 135: New York Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Massachusetts Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: New Jersey Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Pennsylvania Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Connecticut Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Maine Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Vermont Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: New Hampshire Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Rhode Island Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Delaware Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: South Region U.S. Orthopedic Procedure Devices Market: Regional Overview and Trends
TABLE 146: South Region U.S. Orthopedic Procedure Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 147: South Region U.S. Orthopedic Procedure Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 148: South Region U.S. Orthopedic Procedure Devices Market, by Device Category, 2021–2035 (US$ Billion)
TABLE 149: South Region U.S. Orthopedic Procedure Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 150: South Region U.S. Orthopedic Procedure Devices Market, by Anatomical Site, 2021–2035 (US$ Billion)
TABLE 151: South Region U.S. Orthopedic Procedure Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 152: South Region U.S. Orthopedic Procedure Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 153: Texas Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Florida Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Georgia Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: North Carolina Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: Tennessee Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 158: South Carolina Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: Alabama Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Mississippi Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: Louisiana Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: Arkansas Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: Kentucky Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Oklahoma Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Virginia Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Maryland Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: West Virginia Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Midwest Region U.S. Orthopedic Procedure Devices Market: Regional Overview and Trends
TABLE 169: Midwest Region U.S. Orthopedic Procedure Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 170: Midwest Region U.S. Orthopedic Procedure Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 171: Midwest Region U.S. Orthopedic Procedure Devices Market, by Device Category, 2021–2035 (US$ Billion)
TABLE 172: Midwest Region U.S. Orthopedic Procedure Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 173: Midwest Region U.S. Orthopedic Procedure Devices Market, by Anatomical Site, 2021–2035 (US$ Billion)
TABLE 174: Midwest Region U.S. Orthopedic Procedure Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 175: Midwest Region U.S. Orthopedic Procedure Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 176: Illinois Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 177: Ohio Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 178: Michigan Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 179: Minnesota Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 180: Indiana Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 181: Wisconsin Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 182: Missouri Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 183: Iowa Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 184: Kansas Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 185: Nebraska Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 186: North Dakota Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 187: South Dakota Orthopedic Procedure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 188: U.S. Orthopedic Procedure Devices Market: Competitive Landscape Snapshot, 2025
TABLE 189: U.S. Orthopedic Procedure Devices Market: Key Company Market Share Analysis, 2025
TABLE 190: U.S. Orthopedic Procedure Devices Market: Company Positioning Matrix
TABLE 191: U.S. Orthopedic Procedure Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 192: U.S. Orthopedic Procedure Devices Market: Robotics and Navigation Capability Benchmarking
TABLE 193: U.S. Orthopedic Procedure Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 194: Stryker Corporation: Company Profile
TABLE 195: Zimmer Biomet Holdings, Inc.: Company Profile
TABLE 196: DePuy Synthes, Johnson & Johnson MedTech: Company Profile
TABLE 197: Smith+Nephew plc: Company Profile
TABLE 198: Medtronic plc: Company Profile
TABLE 199: Globus Medical, Inc.: Company Profile
TABLE 200: Enovis Corporation: Company Profile
TABLE 201: Arthrex, Inc.: Company Profile
TABLE 202: CONMED Corporation: Company Profile
TABLE 203: Aesculap, Inc., B. Braun: Company Profile
TABLE 204: Integra LifeSciences Holdings Corporation: Company Profile
TABLE 205: Orthofix Medical Inc.: Company Profile
TABLE 206: Alphatec Holdings, Inc.: Company Profile
TABLE 207: ZimVie Inc.: Company Profile
TABLE 208: Exactech, Inc.: Company Profile
TABLE 209: MicroPort Orthopedics Inc.: Company Profile
TABLE 210: Acumed LLC: Company Profile
TABLE 211: Treace Medical Concepts, Inc.: Company Profile
TABLE 212: SI-BONE, Inc.: Company Profile
TABLE 213: Paragon 28, Inc.: Company Profile
TABLE 214: Bioventus Inc.: Company Profile
TABLE 215: LifeNet Health: Company Profile
TABLE 216: RTI Surgical, Inc.: Company Profile
TABLE 217: THINK Surgical, Inc.: Company Profile
TABLE 218: OSSIO Ltd.: Company Profile
TABLE 219: U.S. Orthopedic Procedure Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 220: U.S. Orthopedic Procedure Devices Market: Disruptive Technologies Impact Matrix
TABLE 221: U.S. Orthopedic Procedure Devices Market: Emerging Business Trends
TABLE 222: U.S. Orthopedic Procedure Devices Market: Business Opportunities for Startups and Existing Players
TABLE 223: U.S. Orthopedic Procedure Devices Market: Investment Prioritization Matrix
TABLE 224: U.S. Orthopedic Procedure Devices Market: Market White-Space Analysis
TABLE 225: U.S. Orthopedic Procedure Devices Market: Technology Adoption Curve, 2026–2035
TABLE 226: U.S. Orthopedic Procedure Devices Market: Future Site-of-Care Analysis
TABLE 227: U.S. Orthopedic Procedure Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 228: U.S. Orthopedic Procedure Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 229: U.S. Orthopedic Procedure Devices Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 230: U.S. Orthopedic Procedure Devices Market: Strategic Recommendations for Orthopedic Surgeons and Specialty Practices
TABLE 231: U.S. Orthopedic Procedure Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 232: U.S. Orthopedic Procedure Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 233: U.S. Orthopedic Procedure Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 234: U.S. Orthopedic Procedure Devices Market: Go-to-Market Strategy Considerations
TABLE 235: U.S. Orthopedic Procedure Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 236: U.S. Orthopedic Procedure Devices Market: Robotic and Digital Platform Commercialization Strategy
TABLE 237: U.S. Orthopedic Procedure Devices Market: Ambulatory Surgery Center Market-Entry Strategy
TABLE 238: U.S. Orthopedic Procedure Devices Market: Clinical and Health Economic Evidence Strategy
TABLE 239: U.S. Orthopedic Procedure Devices Market: Pricing, Contracting, and Vendor Standardization Strategy
TABLE 240: U.S. Orthopedic Procedure Devices Market: State-Level Commercial Prioritization Strategy
TABLE 241: U.S. Orthopedic Procedure Devices Market: Merger, Acquisition, and Partnership Opportunity Assessment
TABLE 242: U.S. Orthopedic Procedure Devices Market: Scope Limitation
TABLE 243: U.S. Orthopedic Procedure Devices Market: Data Use Limitation
TABLE 244: U.S. Orthopedic Procedure Devices Market: Forecasting Limitation
TABLE 245: U.S. Orthopedic Procedure Devices Market: Legal Disclaimer
TABLE 246: U.S. Orthopedic Procedure Devices Market: Third-Party Data Disclaimer
TABLE 247: U.S. Orthopedic Procedure Devices Market: Market Estimation and Rounding Disclaimer
TABLE 248: U.S. Orthopedic Procedure Devices Market: Company and Product Information Disclaimer
TABLE 249: U.S. Orthopedic Procedure Devices Market: Regulatory and Reimbursement Disclaimer

List of Figures

FIGURE 1: U.S. Orthopedic Procedure Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Framework
FIGURE 4: Value Chain Analysis
FIGURE 5: Supply Chain Analysis
FIGURE 6: PESTEL Analysis
FIGURE 7: Porter’s Five Forces Analysis
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Orthopedic Clinical Workflow Economics Framework
FIGURE 12: Hospital Capital Procurement Decision Framework
FIGURE 13: Ambulatory Surgery Center Procedure Economics Framework
FIGURE 14: U.S. Orthopedic Procedure Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 15: U.S. Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 16: U.S. Orthopedic Procedure Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 17: Device Category Segment Market Share Analysis, 2025 & 2035
FIGURE 18: Device Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Joint Reconstruction Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Trauma Fixation Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Spine Procedure Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Sports Medicine and Arthroscopy Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Extremity Procedure Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Orthopedic Instruments and Power Tools Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Orthobiologic and Bone-Healing Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Procedure Type Segment Market Share Analysis, 2025 & 2035
FIGURE 27: Procedure Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Joint Arthroplasty Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Fracture Fixation and Trauma Reconstruction Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Spinal Fusion, Decompression, and Stabilization Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Arthroscopy and Soft-Tissue Repair Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Extremity Reconstruction and Corrective Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Revision and Salvage Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Anatomical Site Segment Market Share Analysis, 2025 & 2035
FIGURE 35: Anatomical Site Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Knee Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Hip and Pelvis Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Spine Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Shoulder Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Foot and Ankle Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Hand and Wrist Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Elbow Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Other Anatomical Sites Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 45: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Conventional Manual Procedure Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Powered Surgical Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Minimally Invasive and Arthroscopic Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Navigation and Robotic-Assisted Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Patient-Specific and Three-Dimensional Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Smart, Sensor-Enabled, and AI-Assisted Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 53: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Orthopedic Specialty Hospitals and Clinics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Academic Medical Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Community and Rural Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 60: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: West Region U.S. Orthopedic Procedure Devices Market Share and Leading Players, 2025
FIGURE 62: West Region Market Share Analysis by State, 2025
FIGURE 63: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: California Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Washington Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Arizona Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Colorado Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Oregon Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Utah Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Nevada Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New Mexico Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Idaho Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Montana Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Wyoming Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Alaska Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Hawaii Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Northeast Region U.S. Orthopedic Procedure Devices Market Share and Leading Players, 2025
FIGURE 78: Northeast Region Market Share Analysis by State, 2025
FIGURE 79: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: New York Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Massachusetts Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: New Jersey Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Pennsylvania Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Connecticut Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Maine Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Vermont Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: New Hampshire Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Rhode Island Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Delaware Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: South Region U.S. Orthopedic Procedure Devices Market Share and Leading Players, 2025
FIGURE 91: South Region Market Share Analysis by State, 2025
FIGURE 92: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Texas Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Florida Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Georgia Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: North Carolina Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Tennessee Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: South Carolina Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Alabama Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Mississippi Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Louisiana Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Arkansas Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Kentucky Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Oklahoma Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Virginia Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Maryland Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: West Virginia Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Midwest Region U.S. Orthopedic Procedure Devices Market Share and Leading Players, 2025
FIGURE 109: Midwest Region Market Share Analysis by State, 2025
FIGURE 110: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Illinois Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Ohio Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Michigan Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Minnesota Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Indiana Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Wisconsin Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Missouri Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Iowa Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Kansas Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Nebraska Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: North Dakota Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: South Dakota Orthopedic Procedure Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 123: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 124: Company Positioning Matrix
FIGURE 125: Key Player Product Portfolio Benchmarking
FIGURE 126: Robotics and Navigation Capability Benchmarking
FIGURE 127: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 128: Orthopedic Procedure Device Innovation Roadmap
FIGURE 129: Robotic-Assisted Orthopedic Surgery Adoption Roadmap
FIGURE 130: Outpatient Joint Replacement Opportunity Map
FIGURE 131: Patient-Specific and 3D-Printed Implant Growth Roadmap
FIGURE 132: Smart and Sensor-Enabled Orthopedic Technology Roadmap
FIGURE 133: Future Market Scenario Analysis, 2026–2035
FIGURE 134: Disruptive Technologies Impact Matrix
FIGURE 135: Emerging Business Trends Matrix
FIGURE 136: Investment Prioritization Matrix
FIGURE 137: Market White-Space Opportunity Map
FIGURE 138: Orthopedic Procedure Site-of-Care Shift, 2026–2035
FIGURE 139: Strategic Growth Roadmap for U.S. Orthopedic Procedure Device Companies
FIGURE 140: Go-to-Market Strategy Framework
FIGURE 141: Product Positioning and Portfolio Expansion Framework
FIGURE 142: Robotic and Digital Platform Commercialization Framework
FIGURE 143: Ambulatory Surgery Center Market-Entry Framework
FIGURE 144: Clinical and Health Economic Evidence Framework
FIGURE 145: Pricing and Vendor Standardization Framework
FIGURE 146: State-Level Commercial Prioritization Framework
FIGURE 147: Merger, Acquisition, and Partnership Opportunity Framework
FIGURE 148: Report Scope and Disclaimer Framework